SCP-9123
Unknown
~
medium confidence
SCP-9123
Expected annual
$55.0M
One-time setup
$210.9M
Annual recurring
$53.6M
Personnel
28
One-time programmatic development (specialized pharmaceutical R&D, manufacturing qualification, and construction of a contingency facility) drives a large up-front cost (~$211M). Ongoing annual mitigation (drug procurement/distribution, diagnostics, research, safe houses, standing MTF, clinical care, and reserves) runs on the order of tens of millions per year (~$53.6M/yr), with incident response and legal/cover costs as major recurring drivers.
One-Time Capital Costs
Total: $210.9M
Annual Recurring Costs
Total: $53.6M/yr
Cost Scenarios
📊
Baseline
(baseline)
$53.6M/yr
Normal year with routine operations, scheduled resupply, diagnostics, research, and standing readiness; no major incidents beyond budgeted reserves.
no major public incidents
routine prophylaxis and diagnostics
scheduled R&D and training
🚨
Minor Incident
$56.0M/yr
Single localized compulsion event requiring extra mobilization, targeted legal/PR response, and additional clinical follow-up.
localized public compulsion event
additional field deployments
moderate media/legal attention
🚨
Major Incident
$78.6M/yr
Large-scale mass-compulsion event or high-profile leak requiring extensive emergency response, large settlements, mass clinical care, safe-house operations, and elevated PR/legal costs.
urban mass compulsion event
fatalities or mass casualties
major public exposure requiring large settlements
Personnel
28 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 20 | [#8] Dedicated Mu-3 roster as specified (20 operatives @ $80k/yr). |
| Medical Officer | 4 | [#8] Support medics included in the support budget line (~$400k total support). |
| Engineer / Maintenance | 4 | [#8] Logistics/maintenance/support staff inferred from support budget (~$400k). |
Confidence Notes
Analyst notes are detailed and enumerate major cost centers with ranges; however wide ranges for pharmaceutical R&D, incident severity, and GoI-related escalation introduce substantial uncertainty. Midpoint-based estimates used for budgeting give medium confidence.